Q2 INTERIM REPORT APRIL - JUNE 2022
READ MORE
Mentice acquires Ankyras solutions from Galgo Medical SL
READ MORE

Mentice Investors

Our solutions help improve patient outcomes and clinical performance one therapy-one patient at a time.

MNTC

Trading information
Short name for Nasdaq First North Growth Market : MNTC

ISIN-code: SE0012673291

The shares are registered by Euroclear Sweden AB

Advisor
FNCA Sweden AB is the Certified Advisor for the company

Important information about Nasdaq First North Growth Market Nasdaq
First North Growth Market is an alternate trading platform managed as a separate organization within NASDAQ Group. Companies listed on Nasdaq First North Growth Market is not managed under the same set of rules as the regulated main list market. The companies follow less complex set of rules and procedures adapted for small growth companies. The risk involved with investment in companies on First North Growth market can therefore be higher than investing in companies on the main market. All companies with shares that is traded on Nasdaq First North Growth Market has a certified advisor that secure and control that the rules are followed.


Dividends

The company has no history of Dividend.

Financial Calendar

26

October

2022

Q3 Interim report Jul – Sept 2022

21

July

2022

Q2 Interim report Apr–Jun 2022

27

April

2022

Q1 Interim report Jan–Mar 2022

27

April

2022

Annual General Meeting 2022

6

April

2022

Annual Report 2021